Shariq Haider

2.9k total citations · 1 hit paper
30 papers, 692 citations indexed

About

Shariq Haider is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Shariq Haider has authored 30 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 15 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Shariq Haider's work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (9 papers) and Cytomegalovirus and herpesvirus research (4 papers). Shariq Haider is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (9 papers) and Cytomegalovirus and herpesvirus research (4 papers). Shariq Haider collaborates with scholars based in Canada, United States and Spain. Shariq Haider's co-authors include Hetty Waskin, Michél Laverdière, Issam Raad, Oliver A. Cornely, Nicholas A. Kartsonis, David Helfgott, Amelia Langston, Pranatharthi Chandrasekar, Rafael F. Duarte and Ameen Patel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Shariq Haider

28 papers receiving 675 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

2021 161 citations Johan Maertens, Galia Rahav et al. The Lancet profile →

Peers

Countries citing papers authored by Shariq Haider

Since Specialization

Citations

This map shows the geographic impact of Shariq Haider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shariq Haider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shariq Haider more than expected).

Fields of papers citing papers by Shariq Haider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shariq Haider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shariq Haider. The network helps show where Shariq Haider may publish in the future.

Co-authorship network of co-authors of Shariq Haider

This figure shows the co-authorship network connecting the top 25 collaborators of Shariq Haider. A scholar is included among the top collaborators of Shariq Haider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shariq Haider. Shariq Haider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection 2024 ·The Journal of Infectious Diseases ·Sunwen Chou, Drew J. Winston, Robin K. Avery, Catherine Cordonnier, Rafael F. Duarte, Shariq Haider, (unknown), Karl S. Peggs, Carlos Solano, Jo‐Anne H. Young, Joan Gu, (unknown), Genovefa A. Papanicolaou	5
2	Eight-week glecaprevir/pibrentasvir in Canadian hepatitis C virus-infected, treatment-naïve, compensated cirrhotic people: CREST study 2024 ·Future Virology ·Brian Conway, Curtis Cooper, (unknown), (unknown), Shariq Haider, (unknown), (unknown), Alexander Wong, Alnoor Ramji	0
3	Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Shariq Haider, (unknown)	2
4	Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial breakdown → 2021 ·The Lancet ·Johan Maertens, Galia Rahav, Dong‐Gun Lee, Alfredo Ponce‐de‐León, (unknown), Н Н Климко, Anne Sonet, Shariq Haider, Juan D. Vélez, Issam Raad, Liang‐Piu Koh, Meinolf Karthaus, Jianying Zhou, Ronen Ben‐Ami, Mary Motyl, Seongah Han, Anjana Grandhi, Hetty Waskin	161
5	Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease 2017 ·Journal of Antimicrobial Chemotherapy ·Oliver A. Cornely, Michael Robertson, Shariq Haider, Andrew Grigg, Michelle Geddes, Mickaël Aoun, Werner Heinz, Issam Raad, Urs Schanz, Ralf G. Meyer, Sarah P. Hammond, Kathleen M. Mullane, Helmut Ostermann, Andrew J. Ullmann, Stefan Zimmerli, Marlou L. P. S. van Iersel, (unknown), Hetty Waskin, Nicholas A. Kartsonis, Johan Maertens	9
6	Chronic obstructive pulmonary disease and HIV: are we appropriately screening? 2016 ·AIDS Care ·(unknown), Nadine Kronfli, Thuva Vanniyasingam, Shariq Haider	9
7	Cutaneous Lupus — “The Pimple That Never Went Away” 2016 ·New England Journal of Medicine ·(unknown), Shariq Haider	1
8	Scholarly Success Among Internal Medicine Residents in Canada 2015 ·Katarzyna J. Jerzak, (unknown), Shariq Haider	1
9	Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia 2014 ·Antimicrobial Agents and Chemotherapy ·Rafael F. Duarte, Javier López‐Jiménez, Oliver A. Cornely, Michél Laverdière, David Helfgott, Shariq Haider, Pranatharthi Chandrasekar, Amelia Langston, John R. Perfect, Lei Ma, Marlou L. P. S. van Iersel, (unknown), Nicholas A. Kartsonis, Hetty Waskin	81
10	Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective 2014 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Michél Laverdière, Eric J. Bow, Coleman Rotstein, Julie Autmizguine, Raewyn Broady, Gary Garber, Shariq Haider, Trana Hussaini, Shahid Husain, Philippe Ovetchkine, (unknown), Yves Théorêt	57
11	The Prospective Antifungal Therapy Alliance^® Registry: A Two‐Centre Canadian Experience 2014 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Shariq Haider, Coleman Rotstein, D. B. HORN, Michél Laverdière, Nkechi Azie	9
12	Melioidosis in a Returned Traveller 2014 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Zain Chagla, Natasha Aleksova, (unknown), (unknown), (unknown), Shariq Haider	10
13	Epidemiology and Risk Factors for Bloodstream Infections in a Home Parenteral Nutrition Program 2013 ·Journal of Parenteral and Enteral Nutrition ·(unknown), Zain Kassam, Faizan Amin, (unknown), Shariq Haider, David Armstrong	22
14	Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals 2013 ·PLoS ONE ·(unknown), Victoria Williams, Brenda L. Coleman, Allison McGeer, Shariq Haider, Christine Lee, (unknown), Ethan Rubinstein, Michael John, Lynn Johnston, Shelly McNeil, Kevin Katz, (unknown), Kathryn N. Suh, Jeff Powis, Stephanie Smith, Geoff Taylor, (unknown), Andrew E. Simor	39
15	Inappropriate use of antibiotics and Clostridium difficile infection 2013 ·American Journal of Infection Control ·Jocelyn A. Srigley, Annie Brooks, (unknown), Deborah Yamamura, Shariq Haider, Dominik Mertz	28
16	Bats, Fever and Adenopathy – What Is the Link? 2013 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·(unknown), (unknown), Ameen Patel, Shariq Haider	3
17	Intestinal Toxemia Botulism in 3 Adults, Ontario, Canada, 2006–2008 2012 ·Emerging infectious diseases ·(unknown), Dean Middleton, Yvonne Whitfield, Felix Tyndel, Shariq Haider, (unknown), Richard H. Swartz, Mark P. Nelder, (unknown), Lisa Landry, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Greg Sanders, John W. Austin	33
18	Successful Use of Posaconazole to Treat Invasive Cutaneous Fungal Infection in a Liver Transplant Patient on Sirolimus 2012 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·(unknown), Ameen Patel, Shariq Haider	9
19	A lethal case of generalized tetanus 2011 ·Canadian Medical Association Journal ·Jocelyn A. Srigley, Shariq Haider, (unknown)	7
20	Systemic Therapy of New World Cutaneous Leishmaniasis: A Case Report and Review Article 2010 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Amir Abadir, Ameen Patel, Shariq Haider	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact